KR20240001982A - Yogurt using rice bran ferment and process for preparing the same - Google Patents
Yogurt using rice bran ferment and process for preparing the same Download PDFInfo
- Publication number
- KR20240001982A KR20240001982A KR1020220078992A KR20220078992A KR20240001982A KR 20240001982 A KR20240001982 A KR 20240001982A KR 1020220078992 A KR1020220078992 A KR 1020220078992A KR 20220078992 A KR20220078992 A KR 20220078992A KR 20240001982 A KR20240001982 A KR 20240001982A
- Authority
- KR
- South Korea
- Prior art keywords
- rice bran
- yogurt
- lactic acid
- acid bacteria
- medium
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 114
- 235000009566 rice Nutrition 0.000 title claims abstract description 114
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 96
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 37
- 240000007594 Oryza sativa Species 0.000 title description 98
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 176
- 241000894006 Bacteria Species 0.000 claims abstract description 96
- 239000004310 lactic acid Substances 0.000 claims abstract description 88
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 88
- 239000002609 medium Substances 0.000 claims abstract description 44
- 235000021107 fermented food Nutrition 0.000 claims abstract description 14
- 239000001963 growth medium Substances 0.000 claims abstract description 12
- 241000209094 Oryza Species 0.000 claims abstract 16
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 38
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 38
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 38
- 229960003104 ornithine Drugs 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000004475 Arginine Substances 0.000 claims description 19
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 18
- 238000012258 culturing Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 235000000346 sugar Nutrition 0.000 claims description 15
- 239000006872 mrs medium Substances 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 241000191996 Pediococcus pentosaceus Species 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 5
- 238000007865 diluting Methods 0.000 claims description 5
- 230000006870 function Effects 0.000 abstract description 24
- 235000019640 taste Nutrition 0.000 abstract description 15
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 206010019133 Hangover Diseases 0.000 abstract description 12
- 239000003963 antioxidant agent Substances 0.000 abstract description 11
- 230000003908 liver function Effects 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 4
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 239000012531 culture fluid Substances 0.000 abstract description 2
- 239000010903 husk Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 235000009697 arginine Nutrition 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- 238000000855 fermentation Methods 0.000 description 13
- 230000004151 fermentation Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 8
- 240000005979 Hordeum vulgare Species 0.000 description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000021395 porridge Nutrition 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- 235000015140 cultured milk Nutrition 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- -1 iron salt compounds Chemical class 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 5
- 235000020183 skimmed milk Nutrition 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 206010028813 Nausea Diseases 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000008693 nausea Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000011177 media preparation Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 150000003623 transition metal compounds Chemical class 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- HYUJIYRRLKBBBT-UHFFFAOYSA-N COO[Si](OOC)(OOC)OOC Chemical compound COO[Si](OOC)(OOC)OOC HYUJIYRRLKBBBT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 229940043430 calcium compound Drugs 0.000 description 2
- 150000001674 calcium compounds Chemical class 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 229960003885 sodium benzoate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XQMTUIZTZJXUFM-UHFFFAOYSA-N tetraethoxy silicate Chemical compound CCOO[Si](OOCC)(OOCC)OOCC XQMTUIZTZJXUFM-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- JKXYHWKILNVPGC-RZVRUWJTSA-N (2s)-2,5-bis(azanyl)pentanoic acid Chemical compound NCCC[C@H](N)C(O)=O.NCCC[C@H](N)C(O)=O JKXYHWKILNVPGC-RZVRUWJTSA-N 0.000 description 1
- WHIVNJATOVLWBW-PLNGDYQASA-N (nz)-n-butan-2-ylidenehydroxylamine Chemical compound CC\C(C)=N/O WHIVNJATOVLWBW-PLNGDYQASA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000035943 Aphagia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229910004042 HAuCl4 Inorganic materials 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000282374 Puma concolor Species 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PSUBPFRWJHQJIA-UHFFFAOYSA-K [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] Chemical compound [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] PSUBPFRWJHQJIA-UHFFFAOYSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000020687 goji berry extract Nutrition 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 235000013666 improved nutrition Nutrition 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/04—Preservation of milk or milk preparations by freezing or cooling
- A23C3/05—Preservation of milk or milk preparations by freezing or cooling in packages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dairy Products (AREA)
Abstract
본 발명은 쌀겨 배양액을 이용한 요구르트 및 그의 제조 방법에 관한 것으로, 좀 더 상세하게는 풍부한 영양 성분과 맛을 나타낼 뿐만 아니라 항산화 기능, 숙취해소 기능, 간기능 개선 기능, 피로회복 기능 등의 다양한 기능성을 갖는 쌀겨 배양액을 이용한 요구르트 및 그의 제조 방법에 관한 것이다. 본 발명에 따른 쌀겨 요구르트는 기능성과 기호성을 나타내기에 적합한 발효 식품 유래의 유산균과 배지를 적절히 활용하여 제조함으로써 소비자들이 즐겨 선택하여 이용할 수 있다. 또한 순환 자원인 왕겨·미강을 배지의 영양원으로 이용함으로써 재료비가 저렴하여 고부가치의 제품을 제공할 수 있다.The present invention relates to yogurt and its manufacturing method using rice bran culture fluid. In more detail, it not only exhibits rich nutritional ingredients and taste, but also has various functionalities such as antioxidant function, hangover relief function, liver function improvement function, and fatigue recovery function. It relates to yogurt using rice bran culture medium and a method for producing the same. The rice bran yogurt according to the present invention is manufactured by appropriately utilizing lactic acid bacteria and media derived from fermented foods suitable for functionality and palatability, so that consumers can choose and use it. In addition, by using rice husk and rice bran, which are recycled resources, as a nutrient source for the medium, material costs are low and high value-added products can be provided.
Description
본 발명은 쌀겨 배양액을 이용한 요구르트 및 그의 제조 방법에 관한 것으로, 좀 더 상세하게는 풍부한 영양 성분과 맛을 나타낼 뿐만 아니라 항산화 기능, 숙취해소 기능, 간기능 개선 기능, 피로회복 기능 등의 다양한 기능성을 갖는 요구르트 및 그의 제조 방법에 관한 것이다.The present invention relates to yogurt and its manufacturing method using rice bran culture fluid. In more detail, it not only exhibits rich nutritional ingredients and taste, but also has various functionalities such as antioxidant function, hangover relief function, liver function improvement function, and fatigue recovery function. It relates to yogurt and its manufacturing method.
요구르트(Yogurt)는 발효유의 일종으로 우유류에 젖산균을 접종 발효시켜 응고된 호상의 배양물로, 비교적 산이 많고 상쾌한 풍미가 있다. 원료로 전지 우유나 탈지유가 쓰이고 풍미와 외관을 위해 탈지 분유, 가당연유, 한천 등을 첨가하거나 감미료로 설탕, 꿀 등을 첨가하여 균질화한 후, 가열살균(95℃, 5분)하여 이용한다.Yogurt is a type of fermented milk. It is a coagulated culture made by inoculating milk with lactic acid bacteria and fermenting it. It is relatively acidic and has a refreshing flavor. Whole milk or skim milk is used as the raw material, and for flavor and appearance, skim milk powder, sweetened condensed milk, agar, etc. are added, or sugar and honey are added as sweeteners, homogenized, and then heat sterilized (95°C, 5 minutes) before use.
요구르트 제조에 쓰이는 젖산균은 불가리아 젖산간균(Lactobacillus bulgaricus), 스트렙토코쿠스 써모필루스(Streptococcus thermophilus), 호산성 젖산간균(Lacidophillus) 등으로 저온 배양한 다음 제품에 독특한 풍미가 있도록 2-3종을 적당히 배합하여 사용한다. 유산균 발효유의 섭취는 소화 증진 및 정장효과(整腸效果)의 기능을 나타낸다.The lactic acid bacteria used in yogurt production are Bulgarian lactic acid bacilli ( Lactobacillus bulgaricus ), Streptococcus thermophilus ( Streptococcus thermophilus ), and acidophilic lactic acid bacilli ( Lacidophillus ), which are cultured at low temperature and then used in appropriate quantities to give the product a unique flavor. Use in combination. Consumption of lactic acid bacteria fermented milk has the function of improving digestion and intestinal function.
요구르트는 발효유에 있어서 질감은 매우 중요한 품질의 변수로, 입 안에서의 감촉 및 입 안을 감싸는 부드러운 느낌, 맛, 그리고 적절한 수준의 점도를 부여하는 것은 매우 중요하다.For yogurt, texture is a very important quality variable in fermented milk, and it is very important to provide a soft feel, taste, and an appropriate level of viscosity in the mouth.
또한, 발효유 제품의 높은 점도는 세포 외 다당류(exopolysaccharide)를 생산하는 젖산 박테리아 배양체를 이용함으로써 얻을 수 있고, 이와 동시에 점도의 조밀도 또한 매우 중요하다.In addition, high viscosity of fermented milk products can be obtained by using lactic acid bacterial cultures that produce exopolysaccharide, and at the same time, viscosity density is also very important.
최근에는 요구르트의 영양적 가치와 소화흡수 촉진에 의한 효과 보다는 요구르트에 의해서 공급되는 유산균에 의한 건강 증진 효과에 관한 과학적인 연구가 진행되고 있다. 유아의 장내에는 유산균의 일종인 비피도 균을 중심으로 하는 장내 미생물이 균 총을 이루고 있어서 유해 미생물의 정착과 증식을 억제하여 장내 건강을 유지한다. 그 외에도 유산균이 성장하면서 생산하는 젖산에 의한 장 내용물의 pH 저하, 항생 물질의 생산과 독소의 중화 효과로 얻게 되는 항균작용, 항암작용, 면역증진 작용 등이 있다고 한다.Recently, scientific research is being conducted on the health promotion effects of lactic acid bacteria supplied by yogurt rather than the nutritional value of yogurt and its effects on promoting digestion and absorption. In the intestines of infants, intestinal microorganisms centered on Bifidobacterium, a type of lactic acid bacterium, form a flora, which prevents the establishment and proliferation of harmful microorganisms and maintains intestinal health. In addition, it is said to have antibacterial, anticancer, and immune-enhancing effects obtained through lowering the pH of intestinal contents due to lactic acid produced as lactic acid bacteria grow, production of antibiotics, and neutralization of toxins.
이러한 요구르트는 우유의 영양과 소화율이 향상된 유제품으로 독특한 풍미와 다양한 생리적인 기능성으로 인해 세계적으로 수요가 꾸준히 증가하고 있으며, 우리나라에서도 발효유 및 유산균 보급이 점차 확대되어 식이섬유, 올리고당, 비타민, 무기질 등을 강화시켜 기능성 식품 소재를 보강하였을 뿐만 아니라 변비, 위, 간 기능 개선등의 건강 측면을 강조하는 제품을 개발하여 발효유 시장이 더욱 활기를 띠고 있다.Yogurt is a dairy product with improved nutrition and digestibility than milk, and demand is steadily increasing worldwide due to its unique flavor and various physiological functions. In Korea, the distribution of fermented milk and lactic acid bacteria is gradually expanding, providing dietary fiber, oligosaccharides, vitamins, minerals, etc. The fermented milk market is becoming more active by not only strengthening functional food ingredients but also developing products that emphasize health aspects such as constipation, improvement of stomach and liver functions, etc.
요구르트에 관련된 기술로는 한국 공개번호 제10-1999-0047128호(1999년07월05일)에는 구기자 추출물을 제조하는 공정; 요구르트 배지조제 및 살균공정; 및 요구르트 배양 및 균질공정에 의해 제조되는 요구르트가 개시되어 있다.Technologies related to yogurt include a process for producing goji berry extract in Korean Publication No. 10-1999-0047128 (July 5, 1999); Yogurt medium preparation and sterilization process; And yogurt manufactured by yogurt culture and homogenization process is disclosed.
또한, 한국 등록번호 제10-1328362호(2013년11월05일)에는 다양한 유산균, 효모, 비타민 B군, 필수 아미노산 및 글루타티온 등 생리활성 물질이 풍부한 막걸리를 원료로 이용하여, 인체에 유익한 고기능성 요구르트를 제공 방법이 개시되어 있다.In addition, Korean registration number 10-1328362 (November 5, 2013) uses makgeolli, which is rich in bioactive substances such as various lactic acid bacteria, yeast, vitamin B group, essential amino acids, and glutathione, as a raw material, making it a highly functional product that is beneficial to the human body. A method of providing yogurt is disclosed.
한국 등록번호 제10-1408974호(2014년06월11일)에는 발효 촉진 조성물을 이용한 요구르트의 제조방법 및 이 방법에 의해 제조된 요구르트이 개시되어 있는데, 이는 우유 및 당류를 혼합하여 요구르트 믹스를 제조하는 단계(A100); 상기 요구르트 믹스를 살균 및 냉각하는 단계(A200); Korean Registration No. 10-1408974 (June 11, 2014) discloses a method for producing yogurt using a fermentation promoting composition and yogurt produced by this method, which involves producing a yogurt mix by mixing milk and sugars. Step (A100); Sterilizing and cooling the yogurt mix (A200);
상기 A200 단계를 거친 요구르트 믹스에 균주를 접종하는 단계(A300); 및 상기 A300 단계를 거친 요구르트 믹스를 발효시키는 단계(A400);를 포함하여 구성되는 요구르트의 제조방법에 있어서,Inoculating the strain into the yogurt mix that has undergone step A200 (A300); In the method for producing yogurt comprising a step (A400) of fermenting the yogurt mix that has passed the step A300,
상기 A400 단계에서 발효 촉진 조성물을 첨가하되,In step A400, a fermentation promoting composition is added,
상기 발효 촉진 조성물은, 상기 A300 단계를 거친 유구르트 믹스 100 중량부에 대하여, 2 ~ 7 중량부로 첨가되며,The fermentation promoting composition is added in an amount of 2 to 7 parts by weight based on 100 parts by weight of the yugurt mix that has undergone the A300 step,
상기 발효 촉진 조성물은, 볼(ball), 플레이크(flake) 또는 분말 형태의 하이드록시 라디칼 생성 조성물, 또는 볼(ball), 플레이크(flake) 또는 분말 형태의 슈퍼 옥사이드 생성 조성물을 적용하되,The fermentation promoting composition is applied as a hydroxy radical generating composition in the form of balls, flakes or powder, or a superoxide generating composition in the form of balls, flakes or powder,
상기 하이드록시 라디칼 생성 조성물은, 코어(100)의 표면에 쉘(200)이 코팅된 구조로 이루어지고, 상기 코어(100)는 제 1 실리카 전구체(10)의 표면에 슈퍼옥사이드 생성 화합물(11)이 고착되어 이루어지며, 상기 쉘(200)은 제 2 실리카 전구체(20)의 표면에 전이금속 화합물(21)이 고착되어 이루어지는 것을 사용하며, The hydroxy radical generating composition consists of a shell 200 coated on the surface of the core 100, and the core 100 coats the surface of the first silica precursor 10 with a superoxide generating compound (11). It is made by sticking, and the shell 200 is made by sticking the transition metal compound 21 to the surface of the second silica precursor 20,
상기 슈퍼 옥사이드 생성 조성물은, 코어(100')의 표면에 쉘(200')이 코팅된 구조로 이루어지고, 상기 코어(100')는 제 1 실리카 전구체(10')의 표면에 슈퍼옥사이드 생성 화합물(11')이 고착되어 이루어지고, 상기 쉘(200')은 제 2 실리카 전구체(20')의 표면에 칼슘화합물(21')이 고착되어 이루어지는 것을 사용하며, The superoxide generating composition has a structure in which a shell 200' is coated on the surface of a core 100', and the core 100' is coated with a superoxide generating compound on the surface of the first silica precursor 10'. (11') is made by fixing, and the shell (200') is made by fixing a calcium compound (21') to the surface of the second silica precursor (20'),
상기 제 1 실리카 전구체(10, 10')는, 실리카졸로써, 02 ~ 10 입자크기의 분말 산화규소(SiO2) 20 ~ 40 중량%에 물 60 ~ 80 중량%를 혼합한 것을 사용하고, The first silica precursor (10, 10') is a silica sol made by mixing 20 to 40 wt% of powdered silicon oxide (SiO2) with a particle size of 02 to 10 and 60 to 80 wt% of water,
상기 슈퍼옥사이드 생성 화합물(11,11')은, 질산은(AgNO3), 염화금(AuCl3, HAuCl4) 또는 염화백금(PtCl4) 중에서 단독 또는 2종 이상 병용하여 사용하며, The superoxide generating compounds (11, 11') are used alone or in combination of two or more of silver nitrate (AgNO3), gold chloride (AuCl3, HAuCl4), or platinum chloride (PtCl4);
상기 제 2 실리카 전구체(20, 20')는, 테트라에톡시오르소실리케이트(TEOS), 메틸트리메톡시실란(MTMS), 테트라메톡시오르소실리케이트(TMOS), 테트라프록톡시오르소실리케이트(TPOS), 테트라부톡시오르소실리케이트(TBOS), 테트라 펜톡시오르로실리케이트(TPEOS), 테트라(메틸에틸케토옥시모)실란, 비닐옥시모실란(VOS), 페닐 트리스(부타논옥심)실란(POS) 또는 메칠옥시모실란(MOS) 중에서 단독 또는 2종 이상 병용하여 사용하며,The second silica precursor (20, 20') is tetraethoxyorthosilicate (TEOS), methyltrimethoxysilane (MTMS), tetramethoxyorthosilicate (TMOS), and tetraprocoxyorthosilicate (TPOS). ), tetrabutoxyorthosilicate (TBOS), tetrapentoxyorrosilicate (TPEOS), tetra(methylethylketooxymo)silane, vinyloxymosilane (VOS), phenyl tris(butanone oxime)silane (POS) or methyloxymosilane (MOS), used alone or in combination of two or more types,
상기 전이금속 화합물(21)은, 철염 화합물 또는 구리염 화합물 중에서 단독 또는 병용하여 사용하고, 상기 칼슘화합물(21')은, 칼슘옥사이드 또는 칼슘하이드록시옥사이드 중에서 단독 또는 병용하여 사용하는 것을 특징으로 하고 있다.The transition metal compound (21) is used singly or in combination among iron salt compounds or copper salt compounds, and the calcium compound (21') is used singly or in combination among calcium oxide or calcium hydroxyoxide, there is.
한국 공개번호 제10-2019-0052193호(2019년05월16일)에는 발효시킬 보리쌀을 준비하여 세척한 후 물에 침지시켜 상기 보리쌀을 불리는 보리쌀 세척 및 침지 단계(S100); 상기 침지되어 불려진 보리쌀에서 물을 제거한 후 발효균과 혼합하는 보리쌀 및 발효균 혼합 단계(S200); 상기 발효균과 혼합된 보리쌀을 밀폐 용기에 넣은 후 효모를 증식시켜 발효된 보리 누룩을 제조하는 보리쌀 및 발효균 배양 단계(S300); 멥쌀과 찹쌀을 준비하여 세척한 후 일정한 중량 비율로 혼합하고 물에 침지시켜 불리는 멥쌀 및 찹쌀 혼합 불림 단계(S400); 상기 혼합되어 불려진 멥쌀 및 찹쌀에 물을 혼합한 후 가열하여 죽을 제조하는 멥쌀 및 찹쌀 죽 제조 단계(S500); 상기 멥쌀 및 찹쌀을 이용하여 제조된 죽을 냉각하여 상기 죽에 포함되어 있는 수분의 함량을 조절하는 죽 냉각 단계(S600); 상기 보리 누룩과 죽을 일정한 중량비율로 혼합한 후 숙성시키는 죽 발효 숙성 단계(S700); 및 상기 발효 숙성된죽을 가공하여 제품화하는 가공 단계(S800)를 포함하는 기능성 발효 음료의 제조 방법이 개시되어 있다.In Korea Publication No. 10-2019-0052193 (May 16, 2019), barley rice to be fermented is prepared, washed, and then immersed in water to produce barley rice, which includes a washing and immersion step (S100); A barley rice and fermentation bacteria mixing step (S200) of removing water from the soaked and soaked barley rice and mixing it with fermentation bacteria; A barley rice and fermentation bacteria culture step (S300) of placing the barley rice mixed with the fermentation bacteria in an airtight container and then multiplying the yeast to produce fermented barley yeast; A non-glutinous rice and glutinous rice mixed soaking step (S400) in which non-glutinous rice and glutinous rice are prepared, washed, mixed at a certain weight ratio, and soaked in water; Non-glutinous rice and glutinous rice porridge manufacturing step (S500) of mixing water with the mixed and soaked non-glutinous rice and glutinous rice and then heating to produce porridge; A porridge cooling step (S600) of cooling the porridge prepared using non-glutinous rice and glutinous rice to control the moisture content contained in the porridge; A porridge fermentation and maturation step (S700) in which the barley yeast and porridge are mixed at a certain weight ratio and then aged; A method for producing a functional fermented beverage is disclosed, including a processing step (S800) of processing the fermented and aged porridge to commercialize it.
한국 등록번호 제10-1846277호(2018년04월02일)에는 고구마 본연의 색을 살릴 수 있을뿐만 아니라 향료 또는 색소 등의 첨가제가 첨가되지 않은 자연 건강식 고구마 요구르트 및 이의 제조방법이 개시되어 있다.Korean Registration No. 10-1846277 (April 2, 2018) discloses a natural healthy sweet potato yogurt that not only preserves the natural color of sweet potatoes but also does not contain additives such as flavorings or colorings, and a method for manufacturing the same.
한국 공개번호 제10-2020-0066985호(2020년06월11일)에는 1) 우유, 홍차잎 분말 및 설탕을 혼합하고 살균시킨 후 냉각하여 침전물을 제거하는 단계; 2) 상기 혼합물을 여과하여 밀크티조성물을 제조하는 단계; 3) 상기 조성물에 로즈마리 추출물을 혼합하고, 유산균을 접종하는 단계; 및 4) 상기 유산균을 배양하여 상기 밀크티 조성물을 요구르트로 발효시키는 단계;를 포함하는 항산화 효능이 증진된 밀크티요구르트의 제조 방법이 개시되어 있다.Korean Publication No. 10-2020-0066985 (June 11, 2020) includes the following steps: 1) mixing milk, black tea leaf powder, and sugar, sterilizing, then cooling to remove sediment; 2) filtering the mixture to prepare a milk tea composition; 3) mixing rosemary extract with the composition and inoculating lactic acid bacteria; and 4) culturing the lactic acid bacteria to ferment the milk tea composition into yogurt. A method for producing milk tea yogurt with improved antioxidant efficacy is disclosed.
최근 다양한 발효 기술의 발달과 함께 생활 수준이 향상됨에 따라 여러가지 기능성 제품들이 속속 개발되고 있으며, 이러한 기능성 외에도 맛과 영양성과 기호성이 겸비된 제품에 소비자들의 눈길이 머물 수 있다.Recently, as the standard of living has improved along with the development of various fermentation technologies, various functional products are being developed one after another. In addition to these functions, consumers' attention can be focused on products that combine taste, nutrition, and palatability.
본 발명자들은 풍부한 영양 성분과 맛을 나타낼 뿐만 아니라 항산화 기능, 숙취해소 기능, 간기능 개선 기능, 피로회복 기능 등의 다양한 기능성을 갖는 요구르트를 개발하기 위하여 예의 연구한 결과 후술하는 바와 같이 종균의 성장에 적합한 쌀겨 배양액을 배지로 이용하여 제조된 요구르트가 위와 같은 요건을 만족시킬 수 있음을 발견하고 본 발명을 완성하기에 이르렀다.The present inventors conducted extensive research to develop yogurt that not only has abundant nutrients and taste, but also has various functions such as antioxidant function, hangover relief function, liver function improvement function, and fatigue recovery function. As a result, as described later, it is effective in the growth of starter bacteria. After discovering that yogurt manufactured using a suitable rice bran culture medium as a medium can satisfy the above requirements, the present invention was completed.
따라서 본 발명의 목적은, 일면에 있어서 종균의 성장에 적합한 쌀겨 배양액을 배지로 이용하여 제조함으로써 풍부한 영양 성분과 맛을 나타낼 뿐만 아니라 항산화 기능, 숙취해소 기능, 간기능 개선 기능, 피로회복 기능 등의 다양한 기능성을 갖는 요구르트 및 그의 제조 방법을 제공하는 것에 있다.Therefore, the purpose of the present invention is to produce a rice bran culture medium suitable for the growth of the seed, so that it not only exhibits rich nutrients and taste, but also has antioxidant functions, hangover relief functions, liver function improvement functions, and fatigue recovery functions. The object is to provide yogurt with various functionalities and a method for producing the same.
위와 같은 본 발명의 목적은, 일면에 있어서The object of the present invention as described above is, in one aspect,
a) 증류수에 쌀겨 또는 쌀겨 추출물 및 아르기닌을 넣고 121℃에서 20분 동안 멸균하여 쌀겨 배지를 제조하는 단계;a) preparing a rice bran medium by adding rice bran or rice bran extract and arginine to distilled water and sterilizing it at 121°C for 20 minutes;
b) 발효식품에서 분리한 유산균 균주를 MRS 배지에서 반복 배양하여 균을 활성화시키는 단계;b) repeatedly culturing the lactic acid bacteria strain isolated from fermented food in MRS medium to activate the bacteria;
c) 오르니틴 형성이 확인된 유산균 균주를 1% 아르기닌(Arginine)을 첨가한 MRS 배지에 접종하는 단계;c) inoculating the lactic acid bacteria strain confirmed to form ornithine into MRS medium supplemented with 1% arginine;
d) 유산균 균주가 접종된 배지를 37℃에서 48시간 동안 1차 배양하는 단계;d) primary culturing the medium inoculated with the lactic acid bacteria strain at 37°C for 48 hours;
e) 배양이 완료된 배지를 3,500 RPM에서 20분 동안 원심분리하여 유산균과 배지를 분리하는 단계;e) centrifuging the cultured medium at 3,500 RPM for 20 minutes to separate the lactic acid bacteria and the medium;
f) 배지에서 분리한 유산균에 멸균수를 넣어 세척하는 단계;f) washing the lactic acid bacteria isolated from the medium with sterilized water;
g) 세척된 유산균에 쌀겨 배지를 첨가한 후 37℃에서 48시간 동안 2차배양하는 단계;g) Adding rice bran medium to the washed lactic acid bacteria and then secondary culturing at 37°C for 48 hours;
h) 유산균이 배양된 쌀겨 배지에 설탕 및 우유를 첨가하여 37℃에서 6시간 동안 발효시켜 쌀겨 요구르트를 제조하는 단계 ;h) adding sugar and milk to the rice bran medium cultured with lactic acid bacteria and fermenting it at 37°C for 6 hours to produce rice bran yogurt;
i) 제조된 쌀겨 요구르트를 일정 단위로 포장하는 단계; 및i) packaging the prepared rice bran yogurt in a certain unit; and
j) 포장된 쌀겨 요구르트를 냉장 보관하는 단계;를 포함하는 것을 특징으로 하는 쌀겨 요구르트의 제조 방법에 의해 달성될 수 있다.j) refrigerating the packaged rice bran yogurt.
본 발명에 따른 쌀겨 요구르트는 기능성과 기호성을 나타내기에 적합한 발효 식품 유래의 유산균과 배지를 적절히 활용하여 제조함으로써 소비자들이 즐겨 선택하여 이용할 수 있다. 또한 순환 자원인 왕겨·미강을 배지의 영양원으로 이용함으로써 재료비가 저렴하여 고부가치의 제품을 제공할 수 있다.The rice bran yogurt according to the present invention is manufactured by appropriately utilizing lactic acid bacteria and media derived from fermented foods suitable for functionality and palatability, so that consumers can choose and use it. In addition, by using rice husk and rice bran, which are recycled resources, as a nutrient source for the medium, material costs are low and high value-added products can be provided.
도 1은 본 발명에 따른 쌀겨 추출물을 이용한 요구르트의 제조 공정도이다.
도 2는 본 발명의 쌀겨 배양액을 첨가하여 발효시킨 요구르트의 사진이다.
도 3은 BCP 배지를 이용한 유산균 성장 확인 도면이다.
도 4는 성장이 확인된 오르니틴 활성을 TLC에 의해 확인한 그라프도이다.
도 5는 쌀겨 배양액을 이용하여 제조한 요구르트의 항산화 활성을 나타내는 그라프도이다.
도 6은 쌀겨 배양액을 이용하여 제조한 요구르트의 폴리페놀 함량을 나타내느 그라프도이다.
도 7은 TLC 판을 이용하여 유산균의 오르니틴 생성율 확인하는 사진이다.
도 8은 오르니틴 스탠다드를 나타내는 그라프도이다.
도 9는 본 발명의 유산균 균주에 대한 미생물 기탁 정보를 나타내는 사진이다.Figure 1 is a manufacturing process diagram of yogurt using rice bran extract according to the present invention.
Figure 2 is a photograph of yogurt fermented by adding the rice bran culture medium of the present invention.
Figure 3 is a diagram confirming the growth of lactic acid bacteria using BCP medium.
Figure 4 is a graph showing the ornithine activity in which growth was confirmed by TLC.
Figure 5 is a graph showing the antioxidant activity of yogurt prepared using rice bran culture medium.
Figure 6 is a graph showing the polyphenol content of yogurt prepared using rice bran culture medium.
Figure 7 is a photograph confirming the ornithine production rate of lactic acid bacteria using a TLC plate.
Figure 8 is a graph showing the ornithine standard.
Figure 9 is a photograph showing microorganism deposit information for the lactic acid bacteria strain of the present invention.
본 발명은, 일면에 있어서,The present invention, in one aspect,
a) 증류수에 쌀겨 또는 쌀겨 추출물 및 아르기닌을 넣고 121℃에서 20분 동안 멸균하여 쌀겨 배지를 제조하는 단계;a) preparing a rice bran medium by adding rice bran or rice bran extract and arginine to distilled water and sterilizing it at 121°C for 20 minutes;
b) 발효식품에서 분리한 유산균 균주를 MRS 배지에서 반복 배양하여 균을 활성화시키는 단계;b) repeatedly culturing the lactic acid bacteria strain isolated from fermented food in MRS medium to activate the bacteria;
c) 오르니틴 형성이 확인된 유산균 균주를 1% 아르기닌(Arginine)을 첨가한 MRS 배지에 접종하는 단계;c) inoculating the lactic acid bacteria strain confirmed to form ornithine into MRS medium supplemented with 1% arginine;
d) 유산균 균주가 접종된 배지를 37℃에서 48시간 동안 1차 배양하는 단계;d) primary culturing the medium inoculated with the lactic acid bacteria strain at 37°C for 48 hours;
e) 배양이 완료된 배지를 3,500 RPM에서 20분 동안 원심분리하여 유산균과 배지를 분리하는 단계;e) centrifuging the cultured medium at 3,500 RPM for 20 minutes to separate the lactic acid bacteria and the medium;
f) 배지에서 분리한 유산균에 멸균수를 넣어 세척하는 단계;f) washing the lactic acid bacteria isolated from the medium with sterilized water;
g) 세척된 유산균에 쌀겨 배지를 첨가한 후 37℃에서 48시간 동안 2차배양하는 단계;g) Adding rice bran medium to the washed lactic acid bacteria and then secondary culturing at 37°C for 48 hours;
h) 유산균이 배양된 쌀겨 배지에 설탕 및 우유를 첨가하여 37℃에서 6시간 동안 발효시켜 쌀겨 요구르트를 제조하는 단계 ;h) adding sugar and milk to the rice bran medium cultured with lactic acid bacteria and fermenting it at 37°C for 6 hours to produce rice bran yogurt;
i) 제조된 쌀겨 요구르트를 일정 단위로 포장하는 단계; 및i) packaging the prepared rice bran yogurt in a certain unit; and
j) 포장된 쌀겨 요구르트를 냉장 보관하는 단계;를 포함하는 것을 특징으로 하는 쌀겨 요구르트의 제조 방법을 제공한다.j) refrigerating the packaged rice bran yogurt; providing a method for producing rice bran yogurt, comprising:
본 발명은, 추가의 일면에 있어서, In a further aspect, the present invention,
상기 유산균은The lactic acid bacteria are
a1) 발효 식품을 펩톤수로 희석하는 단계;a1) diluting the fermented food with peptone water;
a2) 희석액을 MRS 배지로 배양하는 단계;a2) culturing the diluted solution with MRS medium;
a3) 배양이 완료된 배지로 부터 콜로니를 얻는 단계;a3) Obtaining colonies from cultured medium;
a4) 콜로니 중에서 환을 형성하지 않으면서 진한 황색을 띄는 균주를 분리하는 단계; 및a4) isolating a dark yellow strain from the colony without forming a ring; and
a5) 분리된 균주의 오르니틴 생산능을 TLC에 의해 조사하는 단계;에 의해 확인하는 것을 특징으로 하는 쌀겨 요구르트의 제조 방법을 제공한다.It provides a method for producing rice bran yogurt, characterized in that it is confirmed by a5) examining the ornithine production ability of the isolated strain by TLC.
본 발명은, 추가의 일면에 있어서, 상기 유산균 균주는 Pediococcus pentosaceus MAC-11(KCCM11359P) 유산균 균주인 것을 특징으로 하는 쌀겨 요구르트의 제조 방법을 제공한다.In a further aspect, the present invention provides a method for producing rice bran yogurt, wherein the lactic acid bacteria strain is Pediococcus pentosaceus MAC-11 (KCCM11359P) lactic acid bacteria strain.
본 발명은, 다른 추가의 일면에 있어서, 상기 방법에 의해 제조된 것을 특징으로 하는 쌀겨 요구르트를 제공한다.In a further aspect, the present invention provides rice bran yogurt produced by the above method.
이하, 본 발명의 쌀겨 요구르트 및 그의 제조 방법에 대하여 바람직한 실시예에 의하여 보다 상세히 설명한다. Hereinafter, the rice bran yogurt of the present invention and its production method will be described in more detail through preferred examples.
이하, 본 개시의 실시를 위한 구체적인 내용을 첨부된 도면을 참조하여 상세히 설명한다. 다만, 이하의 설명에 서는 본 개시의 요지를 불필요하게 흐릴 우려가 있는 경우, 널리 알려진 기능이나 구성에 관한 구체적 설명은 생략하기로 한다.Hereinafter, specific details for implementing the present disclosure will be described in detail with reference to the attached drawings. However, in the following description, detailed descriptions of well-known functions or configurations will be omitted if there is a risk of unnecessarily obscuring the gist of the present disclosure.
첨부된 도면에서, 동일하거나 대응하는 구성요소에는 동일한 참조부호가 부여되어 있다. 또한, 이하의 실시예 들의 설명에 있어서, 동일하거나 대응되는 구성요소를 중복하여 기술하는 것이 생략될 수 있다. 그러나 구성요 소에 관한 기술이 생략되어도, 그러한 구성요소가 어떤 실시예에 포함되지 않는 것으로 의도되지는 않는다.In the accompanying drawings, identical or corresponding components are given the same reference numerals. Additionally, in the description of the following embodiments, overlapping descriptions of the same or corresponding components may be omitted. However, even if descriptions of components are omitted, it is not intended that such components are not included in any embodiment.
개시된 실시예의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 후술되어 있는 실시예 들을 참조하면 명확해질 것이다. 그러나 본 개시는 이하에서 개시되는 실시예들에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 단지 본 실시예들은 본 개시가 완전하도록 하고, 본 개시가 속하는 기술 분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것일 뿐이다.Advantages and features of the disclosed embodiments and methods for achieving them will become clear by referring to the embodiments described below along with the accompanying drawings. However, the present disclosure is not limited to the embodiments disclosed below and may be implemented in various different forms. The present embodiments are merely provided to ensure that the present disclosure is complete and to those skilled in the art to which the present disclosure pertains. It is only provided to fully inform the user of the scope of the invention.
본 명세서에서 사용되는 용어에 대해 간략히 설명하고, 개시된 실시예에 대해 구체적으로 설명하기로 한다. 본 명세서에서 사용되는 용어는 본 개시에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 관련 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 개시에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 개시의 전반에 걸친 내용을 토대로 정의되어야 한다.Terms used in this specification will be briefly described, and the disclosed embodiments will be described in detail. The terms used in this specification are general terms that are currently widely used as much as possible while considering the function in the present disclosure, but this may vary depending on the intention or precedent of a technician working in the related field, the emergence of new technology, etc. In addition, in certain cases, there are terms arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the relevant invention. Therefore, the terms used in this disclosure should be defined based on the meaning of the term and the overall content of this disclosure, rather than simply the name of the term.
본 명세서에서의 단수의 표현은 문맥상 명백하게 단수인 것으로 특정하지 않는 한, 복수의 표현을 포함한다. 또한, 복수의 표현은 문맥상 명백하게 복수인 것으로 특정하지 않는 한, 단수의 표현을 포함한다. 명세서 전체 에서 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In this specification, singular expressions include plural expressions, unless the context clearly specifies the singular. Additionally, plural expressions include singular expressions, unless the context clearly specifies plural expressions. When it is said that a part "includes" a certain element throughout the specification, this means that it may further include other elements rather than excluding other elements, unless specifically stated to the contrary.
호기성 생물체의 필연적인 ROS(활성산소종)의 생성은 건강을 위협하는 요소로써 인체내에 항산화제 존재하지만 노화, 생활습관 등으로 항산화제의 활성이 저하되는데, 본 발명은 항산화 기능을 비롯한 다양한 기능성을 제공함으로써 건강을 유지시키는데 도움이 되는 대중적인 요구르트를 제공하는 것에 기술적인 특징이 있다.The inevitable production of ROS (reactive oxygen species) in aerobic organisms is a factor that threatens health. Although antioxidants exist in the human body, the activity of antioxidants decreases due to aging, lifestyle, etc., and the present invention provides various functions including antioxidant function. There are technical features in providing popular yogurt that helps maintain health by providing it.
도 1은 본 발명에 따른 쌀겨 추출물을 이용한 요구르트의 제조 공정도이고, 도 2는 본 발명의 쌀겨 배양액을 첨가하여 발효시킨 요구르트의 사진이며, 도 3은 BCP 배지를 이용한 유산균 성장 확인 도면이고, 도 4는 성장이 확인된 오르니틴 활성을 TLC에 의해 확인한 그라프도이며, 도 5는 쌀겨 배양액을 이용하여 제조한 요구르트의 항산화 활성을 나타내는 그라프도이고, 도 6은 쌀겨 배양액을 이용하여 제조한 요구르트의 폴리페놀 함량을 나타내느 그라프도이며, 도 7은 TLC 판을 이용하여 유산균의 오르니틴 생성율 확인하는 사진이고, 도 8은 오르니틴 스탠다드를 나타내는 그라프도이고, 도 9는 본 발명의 유산균 균주에 대한 미생물 기탁증의 사진이다.Figure 1 is a manufacturing process diagram of yogurt using rice bran extract according to the present invention, Figure 2 is a photograph of yogurt fermented by adding rice bran culture medium of the present invention, Figure 3 is a diagram confirming the growth of lactic acid bacteria using BCP medium, and Figure 4 is a graph showing the ornithine activity in which growth was confirmed by TLC, Figure 5 is a graph showing the antioxidant activity of yogurt prepared using rice bran culture, and Figure 6 is a graph showing the polyphenol of yogurt prepared using rice bran culture. It is a graph showing the phenol content, Figure 7 is a photograph confirming the ornithine production rate of lactic acid bacteria using a TLC plate, Figure 8 is a graph showing the ornithine standard, and Figure 9 is a graph showing the microorganisms for the lactic acid bacteria strain of the present invention. This is a photo of the deposit certificate.
본 발명에 따른 쌀겨 추출물을 이용한 요구르트의 제조 방법은 도 1에 나타낸 바와 같이 크게 배지 제조 단계, 활성화 단계, 접종 단계, 1차 배양 단계, 분리 단계, 세척 단계, 첨가 단계, 2차 배양 단계, 3차 배양 단계, 포장 단계 및 보관 단계를 포함하여 이루어진다. 이하, 상기 개별 단계에 대하여 구체적으로 설명한다.As shown in Figure 1, the method for producing yogurt using rice bran extract according to the present invention largely consists of a medium preparation step, an activation step, an inoculation step, a primary culture step, a separation step, a washing step, an addition step, a secondary culture step, and 3. It includes the tea cultivation step, packaging step, and storage step. Hereinafter, the individual steps will be described in detail.
a) 배지 제조 단계a) Media preparation steps
증류수에 유산균(젖산균)의 배양을 위한 쌀겨(미강) 또는 쌀겨 추출물을 제조하는 단계로써, 1L 증류수를 기준으로 80 ~ 120g의 쌀겨와 8 ~ 12g의 아르기닌(Arginine)을 넣은 다음 121℃에서 20분 동안 멸균시켜서 유산균 배양용 배지를 조성한다.This is a step of preparing rice bran or rice bran extract for cultivating lactic acid bacteria in distilled water. Based on 1L of distilled water, 80 to 120 g of rice bran and 8 to 12 g of arginine are added and then simmered at 121°C for 20 minutes. Sterilize for a while to create a culture medium for lactic acid bacteria.
쌀겨는 감마오리자놀(γ-oryzanol)을 다량 함유하고 있으며, 감마오리자놀은 천연 토코페롤(비타민 E)의 약 200배 가량의 높은 항산화력을 가지고 있는 성분으로써 이를 미생물의 영양원으로 이용함으로써 항산화 및 다양한 기능성을 제공할 수 있다.Rice bran contains a large amount of gamma oryzanol (γ-oryzanol). Gamma oryzanol is an ingredient with a high antioxidant power of about 200 times that of natural tocopherol (vitamin E). By using it as a nutritional source for microorganisms, it provides antioxidant and various functional properties. can be provided.
상기 쌀겨의 함량은 유산균의 적절한 증식을 위하여 증류수 100 중량부를 기준으로 80 ~ 12 중량부로 포함되는 것이 바람직할 수 있다.The content of the rice bran may be preferably 80 to 12 parts by weight based on 100 parts by weight of distilled water for appropriate growth of lactic acid bacteria.
쌀겨 추출물을 멸균할 때는 자동멸균솥(autoclave)의 온도가 90 ~ 100℃가 되었을 때 작동을 멈추고 쌀겨 추출물을 넣어 멸균시키는 것이 바람직할 수 있다.When sterilizing rice bran extract, it may be desirable to stop operation when the temperature of the autoclave reaches 90 to 100°C and add rice bran extract to sterilize.
상기 아르기닌(L-Arginine)을 유산균이 오르니틴(L-Ornithine)을 생성하는데 필요한 성분으로써, 아르기닌은 생산지 및 공정에 따라 맛이 달라질 수 있으며 아르기닌 함량이 높을 경우 쓴맛이 강할 수 있으므로, 바람직한 아르기닌의 함량은 증류수 100 중량부를 기준으로 0.8 ~ 1.2 중량부로 포함하는 것이 바람직할 수 있다.The arginine (L-Arginine) is a necessary ingredient for lactic acid bacteria to produce ornithine (L-Ornithine). The taste of arginine may vary depending on the production location and process, and if the arginine content is high, the bitter taste may be strong, so arginine is preferred. The content may preferably be 0.8 to 1.2 parts by weight based on 100 parts by weight of distilled water.
b) 활성화 단계b) Activation phase
별도로, 1% 아르기닌을 첨가한 MRS[DE MAN, ROGOSA and SHARPE(MRS) 아가 배지(Difco, Detroit, MI, USA)에 발효식품(예, 청국장)에서 분리한 유산균 균주 또는 페디오코커스 펜토사세우스(Pediococcus pentosaceus) MAC-11 유산균 균주를 37℃에서 48시간 동안 반복 배양하여 균을 활성화시킨다.Separately, lactic acid bacteria strains or Pediococcus pentosacea isolated from fermented foods (e.g. Cheonggukjang) were cultured on MRS [DE MAN, ROGOSA and SHARPE (MRS) agar medium (Difco, Detroit, MI, USA) supplemented with 1% arginine. Pediococcus pentosaceus MAC-11 lactic acid bacteria strain is repeatedly cultured at 37°C for 48 hours to activate the bacteria.
상기 MRS 배지는 10 g/L isomalto-oligosaccharides, 40 g/L lactose, 10 g/L peptone, 10 g/L beef extract, 5g/L yeast extract, 7 g/L sodium acetate, 2 g/L disodium phosphate, 2 g/L ammonium citrate, 1 g/L tween 80, 005 g/L MgSO4, 005 g/L maleic acid, 05 g/L MnSO4, 05 g/L L-cysteine·HCl을 포함한다.The MRS medium contains 10 g/L isosomalto-oligosaccharides, 40 g/L lactose, 10 g/L peptone, 10 g/L beef extract, 5g/L yeast extract, 7 g/L sodium acetate, 2 g/L disodium phosphate. , 2 g/L ammonium citrate, 1 g/L tween 80, 005 g/L MgSO4, 005 g/L maleic acid, 05 g/L MnSO4, 05 g/L L-cysteine·HCl.
상기 유산균의 활성화는 Activation of the lactic acid bacteria is
a1) 발효 식품을 펩톤수로 희석하는 단계;a1) diluting the fermented food with peptone water;
a2) 희석액을 BCP 배지로 배양하는 단계;a2) culturing the diluted solution with BCP medium;
a3) 배양이 완료된 배지로 부터 환을 형성하지 않으면서 진한 황색을 띄는 콜로니를 분리하는 단계; 및a3) Isolating dark yellow colonies without forming rings from the culture medium; and
a4) 분리된 균주의 오르니틴 생산능을 TLC에 의해 확인하는 단계;에 의해 수행하는 것이 바람직할 수 있다.a4) Confirming the ornithine production ability of the isolated strain by TLC.
한편, 발효식품(예, 청국장)에서의 유익한 유산균의 분리는 생리활성 물질의 생산 능력의 지표로써 오르니틴을 생산할 수 있는 유산균을 분리하는 것이 바람직할 수 있다. Meanwhile, when isolating beneficial lactic acid bacteria from fermented foods (e.g., Cheonggukjang), it may be desirable to isolate lactic acid bacteria that can produce ornithine as an indicator of the ability to produce bioactive substances.
구체적으로는, 발효 식품을 펩톤수로 희석하는 단계에서는 발효 식품 시료를 펩톤수로 10-1 ~ 10-8 범위로 희석한다. Specifically, in the step of diluting the fermented food with peptone water, the fermented food sample is diluted with peptone water to a range of 10 -1 to 10 -8 .
상기 발효 식품은, 이에 한정되는 것은 아니며, 청국장, 메주, 된장 등을 대표적인 예로서 들 수 있다.The fermented food is not limited to this, and representative examples include cheonggukjang, meju, and soybean paste.
그 다음, 희석액을 0.1mL씩 분주하여 0.002% Bromocresol purple(BCP)(Sigma Chemical Co. St. Louis, USA)을 첨가한 MRS 배지에서 2~5회 반복 배양하여 균을 활성화시키고, 콜로니를 얻기 위해 37℃에서 48시간 동안 배양하는 것이 바람직할 수 있다. Next, 0.1 mL of the diluted solution was dispensed and cultured 2 to 5 times in MRS medium supplemented with 0.002% Bromocresol purple (BCP) (Sigma Chemical Co. St. Louis, USA) to activate the bacteria and obtain colonies. Incubation at 37°C for 48 hours may be desirable.
상기 배지는 pH의 변화로 색이 변화하는 특징이 있으며 오염 여부와 유산균의 활성화 여부를 확인할 수 있다. 유산균이 성장하게 되면 자색이었던 배지에서 콜로니 주위를 황색으로 변화시킨다.The medium has the characteristic of changing color due to changes in pH, and it is possible to check whether it is contaminated and whether the lactic acid bacteria are activated. When lactic acid bacteria grow, the area around the colony changes from purple to yellow.
콜로니 분리 단계에서는 콜로니 중에서 환을 형성하지 않으면서 진한 노란색을 띄는 것을 유산균 균주의 1차 후보군으로 선정하여 분리한다. In the colony isolation step, colonies that do not form rings and are dark yellow are selected as primary candidates for lactic acid bacteria strains and isolated.
이어서 분리된 균주의 오르니틴 생산능을 TLC에 의해 확인하는 단계에서는 1차 후보군으로 선정된 콜로니를 1% 아르기닌이 첨가된 MRS(Difco, Detroit, MI, USA) 브로쓰에서 37℃에서 48시간 동안 배양한 후 오르니틴 생성능을 TLC를 이용하여 조사한다. Next, in the step of confirming the ornithine production ability of the isolated strain by TLC, colonies selected as primary candidates were grown in MRS (Difco, Detroit, MI, USA) broth supplemented with 1% arginine at 37°C for 48 hours. After culturing, the ability to produce ornithine is examined using TLC.
TLC는 silica gel F254과 표준 오르니틴(Merck, Damstadt, Germany), 이동상 (Butanol: Acetic acid: Dichoromethanol: water= 5:3:3:3)을 이용하여 실시하는 것이 바람직할 수 있다.TLC may be preferably performed using silica gel F 254 , standard ornithine (Merck, Damstadt, Germany), and a mobile phase (Butanol: Acetic acid: Dichoromethanol: water = 5:3:3:3).
유산균의 오르니틴 생성능(생성 시간 효율 포함)을 확인하기 위하여 TLC를 24시간 간격으로 수행하는 것이 바람직할 수 있다. 후술하는 실시예에서 확인되는 바와 같이 측정결과 48시간에 걸쳐 배양시킨 유산균이 더 많은 오르니틴을 생성하는 것으로 나타났다.In order to confirm the ornithine production ability of lactic acid bacteria (including production time efficiency), it may be desirable to perform TLC at 24-hour intervals. As confirmed in the examples described later, the measurement results showed that lactic acid bacteria cultured for 48 hours produced more ornithine.
TLC를 통해 활성을 확인 후 좋은 활성이 확인되어 요구르트 생산 유산균으로 최종 선정하여 사용한다.After checking the activity through TLC, good activity was confirmed and it was finally selected and used as a yogurt production lactic acid bacteria.
상기한 바와 같은 활성화 단계에 의해 발효 식품으로 부터 자연상태에 분리한 균주를 바람직하게 사용할 수 있다.Strains isolated in a natural state from fermented foods through the activation step as described above can be preferably used.
또한, 청국장에서 분리된 유산균 균주인 페디오코커스 펜토사세우스(Pediococcus pentosaceus) MAC-11 균주를 더욱 바람직하게 사용할 수 있다.In addition, Pediococcus pentosaceus MAC-11 strain, a lactic acid bacteria strain isolated from Cheonggukjang, can be more preferably used.
상기 유산균 균주는 아르기닌을 오르니틴으로 전환하는 대사능력을 가진 유산균으로써, 오르니틴은 숙취 해소, 간 기능 개선, 운동 후 피로감 감소 등의 유익한 기능성을 제공할 수 있다.The lactic acid bacteria strain is a lactic acid bacterium with the metabolic ability to convert arginine into ornithine, and ornithine can provide beneficial functions such as relieving hangovers, improving liver function, and reducing fatigue after exercise.
상기 균주는 청국장의 맛을 결정하는 중요한 우점종의 하나로 알려진 페디오코커스((Pediococcus) 속 균주로서, 청국장으로부터 오르니틴을 생성하는 젖산균을 분리하기 위해 브로모크레졸퍼플이 첨가된 배지에서 자란 콜로니 중 환을 형성하지 않고 진한 노란색을 띄는 것들을 후보 균주로 선발하고, 후보 균주의 오르니틴 생성 가능성은 TLC를 이용하여 조사하였으며, TLC를 통하여 오르니틴 생성능이 우수한 4개의 후보 균주로 부터 선발된 것이다.The strain is a strain of the Pediococcus genus known as one of the important dominant species that determines the taste of Cheonggukjang. It is a ring of colonies grown on a medium containing bromocresol purple to isolate lactic acid bacteria that produce ornithine from Cheonggukjang. Those that did not form and were dark yellow were selected as candidate strains, and the possibility of ornithine production of the candidate strains was investigated using TLC. Four candidate strains with excellent ornithine production ability were selected through TLC.
선발된 균주들 중 MAC-11의 형태학적 및 생화학적 특성을 조사한 결과 분리된 균주는 그람 양성, 구균이었으며, 혐기적 조건에서 이산화탄소를 생성하였다. 분리된 유산균 균주는 L-아라비노스, 리보오스, D-자일로스, 글루코오스 등을 분해하여 산을 생성하고, 아도니톨, 솔비톨, 스타치는 분해하지 못하였다(표 1 참조). 선발된 균주는 MRS 배지에서 37℃와 pH 6.5에서 잘 자랐으며, 성장을 위한 온도와 pH는 각각 37℃와 pH 6.5이었다.As a result of examining the morphological and biochemical characteristics of MAC-11 among the selected strains, the isolated strain was Gram-positive, a coccus, and produced carbon dioxide under anaerobic conditions. The isolated lactic acid bacteria strain produced acid by decomposing L-arabinose, ribose, D-xylose, and glucose, but failed to decompose adonitol, sorbitol, and starch (see Table 1). The selected strain grew well in MRS medium at 37°C and pH 6.5, and the temperature and pH for growth were 37°C and pH 6.5, respectively.
상기 표 1에서 +는 양성(positive), -는 음성(negative)을 의미한다.In Table 1, + means positive and - means negative.
상기 균주는 한국 공개번호 제10-2017-0073839호(2017년06월29일)에 공시된 균주로써, 기탁 정보는 후술하는 바와 같다.The above strain is a strain published in Korea Publication No. 10-2017-0073839 (June 29, 2017), and the deposited information is as described below.
d) 접종 단계d) Inoculation step
오르니틴 형성이 확인된 유산균 균주를 1% Arginine을 첨가한 MRS 배지에 접종하는 단계로서, MRS 배지 50mL을 기준으로 유산균 1mL을 접종하는 것이 바람직할 수 있다.As a step of inoculating the lactic acid bacteria strain confirmed to form ornithine into MRS medium supplemented with 1% Arginine, it may be desirable to inoculate 1 mL of lactic acid bacteria based on 50 mL of MRS medium.
e) 1차 배양 단계e) Primary culture step
유산균 균주가 접종된 배지를 37℃에서 24~48시간 동안 1차 배양한다. 배양 시간은 48 시간이 더욱 바람직할 수 있다.The medium inoculated with the lactic acid bacteria strain is first cultured at 37°C for 24 to 48 hours. The incubation time may be more preferably 48 hours.
f) 분리 단계f) separation step
배양이 완료된 배지를 2,500 ~ 5,000RPM에서 20분 동안 원심분리하여 유산균과 배지(MRS broth)를 분리한다.The cultured medium is centrifuged at 2,500 to 5,000 RPM for 20 minutes to separate the lactic acid bacteria and the medium (MRS broth).
g) 세척 단계g) washing step
배지에서 분리한 유산균을 멸균수로 세척한다.Wash the lactic acid bacteria isolated from the medium with sterile water.
h) 2차 배양 단계 h) Secondary culture step
이어서, 세척된 유산균 1g을 기준으로 쌀겨 추출액 50g을 첨가한 후 37℃에서 48시간 동안 2차배양한다.Next, 50 g of rice bran extract is added based on 1 g of washed lactic acid bacteria, and secondary culture is performed at 37°C for 48 hours.
i) 발효 단계i) Fermentation stage
멸균한 유리병에 2차 배양된 쌀겨 추출액 40 ~ 50g을 기준으로 설탕 2g 및 잔량의 우유(탈지유가 더욱 바람직할 수 있음)를 넣어 100이 되게 한다.In a sterilized glass bottle, add 2g of sugar and the remaining amount of milk (skim milk may be more preferable) based on 40 to 50g of secondary cultured rice bran extract to make it 100.
이어서, 37℃에서 6시간 동안 발효시켜 쌀겨 요구르트를 제조한다. 이 때 90~100 rpm으로 진탕 조건하에서 발효를 수행하는 것이 더욱 바람직할 수 있다.Next, rice bran yogurt is prepared by fermenting at 37°C for 6 hours. At this time, it may be more desirable to perform fermentation under shaking conditions at 90 to 100 rpm.
한편, 직접 우유에 아르기닌을 첨가하여 요구르트를 제조할 경우 맛이 떨어지는 문제가 있어서 우유에 아르기닌을 직접 첨가하지 않고 미강 배지에서 유산균을 배양하는 과정 중에 우유를 첨가하여 유산균의 발효에 의한 개선된 방식을 제공할 수 있으며, 이는 본 발명의 다른 특징을 구성한다.On the other hand, when making yogurt by adding arginine directly to milk, there is a problem of poor taste, so instead of adding arginine directly to milk, an improved method by adding milk during the process of culturing lactic acid bacteria in rice bran medium through fermentation of lactic acid bacteria was used. It can be provided, which constitutes another feature of the present invention.
j) 포장 단계 j) Packaging stage
상기 단계에서 제조된 쌀겨 요구르트는 규격별로 포장용기에 충전하여 포장한다. The rice bran yogurt prepared in the above step is filled into packaging containers according to specifications and packaged.
k) 보관 단계 k) storage phase
포장된 쌀겨 요구르트는 사용전까지 냉장(4~6℃) 보관한다.Store packaged rice bran yogurt in the refrigerator (4-6℃) until use.
이어서, 기준 및 규격에 준하여 성상, 이물질, 수분, 세균수, 대장균 등을 검사한 후 적합품에 한하여 출하한다.Next, the product is inspected for appearance, foreign substances, moisture, bacterial count, E. coli, etc. in accordance with the standards and specifications, and only those that comply are shipped.
본 발명의 쌀겨 요구르트는 그 유효성분 이외에 감미제, 풍미제, 생리활성 성분, 미네랄 등이 포함될 수 있다.The rice bran yogurt of the present invention may contain sweeteners, flavoring agents, bioactive ingredients, minerals, etc. in addition to the active ingredients.
감미제는 식품이 적당한 단맛을 나게 하는 양으로 사용될 수 있으며, 천연의 것이거나 합성된 것일 수 있다. 바람직하게는 천연 감미제를 사용하는 경우인데, 천연 감미제로서는 옥수수 시럽 고형물, 꿀, 수크로오스, 프룩토오스, 락토오스, 말토오스 등의 당 감미제를 들 수 있다.Sweeteners can be used in amounts to give foods an appropriate sweet taste and can be natural or synthetic. Preferably, a natural sweetener is used, and natural sweeteners include sugar sweeteners such as corn syrup solids, honey, sucrose, fructose, lactose, and maltose.
풍미제는 맛이나 향을 좋게 하기 위하여 사용될 수 있는데, 천연의 것과 합성된 것 모두 사용될 수 있다. 바람직하게는 천연의 것을 사용하는 경우이다. 천연의 것을 사용할 경우에 풍미 이외에 영양 강화의 목적도 병행할 수 있다. 천연 풍미제로서는 사과, 레몬, 감귤, 포도, 딸기, 복숭아 등에서 얻어진 것이거나 녹차잎, 둥굴레, 대잎, 계피, 국화 잎, 자스민 등에서 얻어진 것일 수 있다. 또 인삼(홍삼), 죽순, 알로에 베라, 은행 등에서 얻어진 것을 사용할 수 있다. 천연 풍미제는 액상의 농축액이나 고형상의 추출물일 수 있다. 경우에 따라서 합성풍미제가 사용될 수 있는데, 합성 풍미제는 에스테르, 알콜, 알데하이드, 테르펜 등이 이용될 수 있다.Flavoring agents can be used to improve taste or aroma, and both natural and synthetic ones can be used. Preferably, natural products are used. When using natural products, they can serve the purpose of enhancing nutrition in addition to flavor. Natural flavoring agents may be obtained from apples, lemons, tangerines, grapes, strawberries, peaches, etc., or may be obtained from green tea leaves, coriander leaves, bamboo leaves, cinnamon, chrysanthemum leaves, jasmine, etc. You can also use things obtained from ginseng (red ginseng), bamboo shoots, aloe vera, and ginkgo nuts. Natural flavoring agents may be liquid concentrates or solid extracts. In some cases, synthetic flavoring agents may be used, such as esters, alcohols, aldehydes, and terpenes.
생리 활성 물질로서는 카테킨, 에피카테킨, 갈로가테킨, 에피갈로카테킨 등의 카테킨류나, 레티놀, 아스코르브산, 토코페롤, 칼시페롤, 티아민, 리보플라빈 등의 비타민류 등이 사용될 수 있다.As physiologically active substances, catechins such as catechin, epicatechin, gallogatechin, and epigallocatechin, and vitamins such as retinol, ascorbic acid, tocopherol, calciferol, thiamine, and riboflavin can be used.
미네랄로서는 칼슘, 마그네슘, 크롬, 코발트, 구리, 불소화물, 게르마늄, 요오드, 철, 리튬, 마그네슘, 망간, 몰리브덴, 인, 칼륨, 셀레늄, 규소, 나트륨, 황, 바나듐, 아연 등이 사용될 수 있다.As minerals, calcium, magnesium, chromium, cobalt, copper, fluoride, germanium, iodine, iron, lithium, magnesium, manganese, molybdenum, phosphorus, potassium, selenium, silicon, sodium, sulfur, vanadium, zinc, etc. can be used.
또한 본 발명의 쌀겨 요구르트는 상기 감미제 등 이외에도 필요에 따라 산미료 등을 포함할 수 있다.In addition, the rice bran yogurt of the present invention may contain an acidulant, etc., if necessary, in addition to the above-mentioned sweetener.
이러한 산미료 등은 그것이 첨가되는 용도를 달성할 수 있는 한 극미량으로 첨가되어 사용되는 것이 바람직하다. 극미량이란 수치적으로 표현할 때 식품 조성물 전체 중량을 기준으로 할 때 0.0005중량% 내지 약 0.5중량% 범위를 의미한다.It is preferable that these acidulants and the like are added in very small amounts as long as they can achieve the purpose for which they are added. When expressed numerically, trace amount means a range of 0.0005% by weight to about 0.5% by weight based on the total weight of the food composition.
사용될 수 있는 보존제로서는 소듐 소르브산칼슘, 소르브산나트륨, 소르브산칼륨, 벤조산칼슘, 벤조산나트륨, 벤조산칼륨, EDTA(에틸렌디아민테트라아세트산) 등을 들 수 있다.Preservatives that can be used include calcium sodium sorbate, sodium sorbate, potassium sorbate, calcium benzoate, sodium benzoate, potassium benzoate, and EDTA (ethylenediaminetetraacetic acid).
사용될 수 있는 유화제로서는 아카시아검, 카르복시메틸셀룰로스, 잔탄검, 펙틴 등을 들 수 있다.Emulsifiers that can be used include acacia gum, carboxymethylcellulose, xanthan gum, pectin, etc.
사용될 수 있는 산미료로서는 연산, 말산, 푸마르산, 아디프산, 인산, 글루콘산, 타르타르산, 아스코르브산, 아세트산, 인산 등을 들 수 있다. 이러한 산미료는 맛을 증진시키는 목적 이외에 미생물의 증식을 억제할 목적으로 식품 조성물이 적정 산도로 되도록 첨가될 수 있다.Acidulants that can be used include acidic acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, and phosphoric acid. In addition to improving taste, these acidulants may be added to ensure that the food composition has an appropriate acidity for the purpose of inhibiting the growth of microorganisms.
사용될 수 있는 점증제로서는 현탁화 구현제, 침강제, 겔형성제, 팽화제 등을 들 수 있다.Thickening agents that can be used include suspending agents, settling agents, gel forming agents, bulking agents, etc.
본 발명에 따른 쌀겨 요구르트는 바람직한 실시형태에 있어서, 예를 들면 벌꿀, 맥아, 글리세린, 홍삼, 산수유, 복령, 숙지황, 가시오가피, 동충하초, 자몽 추출물, 감초, 맥류약엽분말, 서양산사자추출물, 세인트존스워트, 셀레늄효모, 비타민 C, 구연산, 니코틴산, 안식향산나트륨, 아스파탐, 사카린, 펙틴, 말리톨, 솔비톨, 자일리톨, 구아검, 탈지분유 및 올리고당으로 이루어진 군 중에서 선택되는 하나 이상의 성분을 추가하여 기호도나 미감을 증대시킬 수 있다. 이들은 본 발명의 조성물의 전체 중량을 기준으로 약 50∼80% 로 사용하는 것이 적절하다.In a preferred embodiment, the rice bran yogurt according to the present invention contains, for example, honey, malt, glycerin, red ginseng, Cornus officinalis, Bokryeong, Rehmannia glutinosa, Acanthopanax, Cordyceps sinensis, grapefruit extract, licorice, pulse medicinal leaf powder, Western mountain lion extract, and St. John's wort. , selenium yeast, vitamin C, citric acid, nicotinic acid, sodium benzoate, aspartame, saccharin, pectin, malitol, sorbitol, xylitol, guar gum, skim milk powder, and oligosaccharides to add preference or taste. It can be increased. It is appropriate to use them in an amount of about 50 to 80% based on the total weight of the composition of the present invention.
(실시예)(Example)
이하, 본 발명을 하기의 실시예에 의거하여 좀 더 상세하게 설명한다. 이들 실시예는 본 발명을 더욱 용이하게 설명할 목적으로 제시된 것으로서, 본 발명이 이들 실시예에 의해 한정되는 것이 아니고, 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 치환 및 균등한 타 실시예로 변경할 수 있음을 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 명백할 것이다.Hereinafter, the present invention will be described in more detail based on the following examples. These examples are presented for the purpose of more easily explaining the present invention, and the present invention is not limited by these examples, but can be substituted or changed to other equivalent embodiments without departing from the technical spirit of the present invention. It will be clear to those skilled in the art that this invention can be done.
실시예 1: 청국장으로 부터 유산균의 분리Example 1: Isolation of lactic acid bacteria from Cheonggukjang
시중에서 구입한 청국장을 펩톤수로 10-1 ~ 10-8 범위로 희석한 후 희석액을 0.1mL씩 분주하여 BCP 배지[0.002% Bromocresol purple(BCP)(Sigma Chemical Co. St. Louis, USA)을 첨한 MRS 배지]에서 37℃에서 48시간 동안 2회 반복 배양하여 균을 활성화시켰다. 생성된 콜로니 중에서 환을 형성하지 않으면서 진한 노란색을 띄는 것을 유산균 균주의 1차 후보군으로 선정하여 분리하였다. 성장한 균의 성상은 도 3에 나타내었다. 도 3은 BCP 배지를 이용한 유산균 성장 확인 도면이다.After diluting commercially purchased cheonggukjang with peptone water in the range of 10 -1 to 10 -8 , 0.1 mL of the dilution was dispensed and mixed with BCP medium [0.002% Bromocresol purple (BCP) (Sigma Chemical Co. St. Louis, USA). The bacteria were activated by repeated culturing twice for 48 hours at 37°C in [MSS medium supplemented]. Among the resulting colonies, those that did not form rings and were dark yellow were selected as primary candidates for lactic acid bacteria strains and isolated. The characteristics of the grown bacteria are shown in Figure 3. Figure 3 is a diagram confirming the growth of lactic acid bacteria using BCP medium.
1차 후보군으로 선정된 콜로니를 1% 아르기닌이 첨가된 MRS(Difco, Detroit, MI, USA) 브로쓰에서 37℃에서 48시간 동안 배양한 후 오르니틴 생성능을 TLC를 이용하여 조사하고, 그 결과를 도 4에 나타내었다. 도 4는 성장이 확인된 오르니틴 활성(황색)을 TLC에 의해 확인한 그라프도이다.Colonies selected as primary candidates were cultured in MRS (Difco, Detroit, MI, USA) broth supplemented with 1% arginine at 37°C for 48 hours, and the ability to produce ornithine was examined using TLC, and the results were reported. It is shown in Figure 4. Figure 4 is a graph showing ornithine activity (yellow) in which growth was confirmed by TLC.
TLC는 silica gel F254과 표준 오르니틴(Merck, Damstadt, Germany), 이동상 (Butanol: Acetic acid: Dichoromethanol: water= 5:3:3:3)을 이용하여 실시하였다. 측정결과 48시간에 걸쳐 배양시킨 유산균이 더 많은 오르니틴을 생성하는 것으로 나타났다.TLC was performed using silica gel F 254 , standard ornithine (Merck, Damstadt, Germany), and mobile phase (Butanol: Acetic acid: Dichoromethanol: water = 5:3:3:3). The measurement results showed that lactic acid bacteria cultured for 48 hours produced more ornithine.
실시예 2: 쌀겨 요구르트의 제조Example 2: Preparation of rice bran yogurt
1L 증류수에 100g의 쌀겨, 10g의 아르기닌을 넣어 121℃에서 20분 동안 멸균시켜 쌀겨 추출액을 얻었다. 멸균기(autoclave)의 온도가 90~100℃가 되었을 때 작동을 멈추고 쌀겨 추출물을 넣어 멸균시켰다.100 g of rice bran and 10 g of arginine were added to 1 L of distilled water and sterilized at 121°C for 20 minutes to obtain a rice bran extract. When the temperature of the autoclave reached 90~100℃, it stopped working and rice bran extract was added to sterilize it.
실시예 1에서 오르니틴 형성이 확인된 유산균 균주 1mL을 1% Arginine을 첨가한 MRS 배지 50mL에 접종하였다. 유산균 균주가 접종된 배지를 37℃에서 48시간 동안 1차 배양한 후 배양이 완료된 배지를 3,500 RPM에서 20분 동안 원심분리하여 유산균과 배지(MRS broth)를 분리한 후 배지에서 분리한 유산균을 멸균수로 세척하고, 세척된 유산균 1g을 기준으로 쌀겨 추출액 50g을 첨가한 후 37℃에서 48시간 동안 2차배양하였다. 멸균한 2개의 유리병에 각각의 2차 배양된 쌀겨 추출액 40 및 50g을 넣고 설탕 2g 및 잔량의 탈지유를 100g이 되게 하여 90~100 rpm으로 37℃에서 6시간 동안 발효시켜 쌀겨 요구르트를 제조하였다(도 2참조).1 mL of the lactic acid bacteria strain confirmed to form ornithine in Example 1 was inoculated into 50 mL of MRS medium supplemented with 1% Arginine. After primary cultivation of the medium inoculated with the lactic acid bacteria strain at 37°C for 48 hours, the cultured medium was centrifuged at 3,500 RPM for 20 minutes to separate the lactic acid bacteria from the medium (MRS broth), and then the lactic acid bacteria isolated from the medium were sterilized. It was washed with water, 50 g of rice bran extract was added based on 1 g of the washed lactic acid bacteria, and secondary culture was performed at 37°C for 48 hours. Rice bran yogurt was prepared by placing 40 and 50 g of each secondary cultured rice bran extract in two sterilized glass bottles, adding 2 g of sugar and the remaining amount of skim milk to 100 g, and fermenting at 90-100 rpm at 37°C for 6 hours ( (see Figure 2).
실시예 3: 쌀겨 요구르트의 제조Example 3: Preparation of rice bran yogurt
실시예 2에 준하여 쌀겨 요구르트를 제조하되, 유산균은 청국장에서 분리한 페디오코커스 펜토사세우스(Pediococcus pentosaceus) MAC-11(KCCM11359P)을 사용하였다.Rice bran yogurt was prepared according to Example 2, except that the lactic acid bacteria used were Pediococcus pentosaceus MAC-11 (KCCM11359P) isolated from Cheonggukjang.
시험예 1: 쌀겨 요구르트의 항산화능 분석Test Example 1: Analysis of antioxidant activity of rice bran yogurt
실시예 2에서 제조한 요구르트에 대하여 DPPH와 아미노산 추출을 진행하여 요구르트에 항산화와 Ornithine 함량을 확인하였다.DPPH and amino acid extraction were performed on the yogurt prepared in Example 2 to confirm the antioxidant and ornithine contents of the yogurt.
시중 요구르트, 당 2% 미강 스타터 40% 함유 요구르트, 당 2% 미강스타터 50% 함유 요구르트를 시료로 사용하기 위해 동결건조하였고, 비타민 C를 대조군(control)으로 하였다. 각 시료와 비타민 C를 EP tube에 5mg 정량 후 DW로 농도별 희석하여 사용하였다. 96 well plate에 라벨링 후 색보정에 100% EtOH를 200㎕씩 분주하고, 대조군에 100% EtOH 50㎕을 분주하였다. 색보정과 감체에 각각 시료 50㎕ 분주하고, 대조군과 검체에 0.2mM DPPH 200㎕ 분주 후 30분 동안 상온, 암소에서 방치하였다. TECAN을 이용하여 517nm로 흡광도 측정하고 그 결과를 도5에 나타내었다. 도 5는 쌀겨 배양액을 이용하여 제조한 요구르트의 항산화 활성을 나타내는 그라프도이다.Commercial yogurt, yogurt containing 2% sugar and 40% rice bran starter, and yogurt containing 50% rice bran starter with 2% sugar were freeze-dried to be used as samples, and vitamin C was used as a control. Each sample and vitamin C were quantified at 5 mg in an EP tube and then diluted by concentration with DW before use. After labeling on a 96 well plate, 200 ㎕ of 100% EtOH was dispensed for color correction, and 50 ㎕ of 100% EtOH was dispensed into the control group. 50㎕ of sample was dispensed into each of the color correction and detection groups, and 200㎕ of 0.2mM DPPH was dispensed into the control group and specimen and left at room temperature in the dark for 30 minutes. Absorbance was measured at 517 nm using TECAN, and the results are shown in Figure 5. Figure 5 is a graph showing the antioxidant activity of yogurt prepared using rice bran culture medium.
도 5의 결과로 부터 확인되는 바와 같이, 본 발명의 쌀겨 요구르트는 시중 제품에 비하여 항산화능이 더 우수한 것으로 나타났다.As confirmed from the results in Figure 5, the rice bran yogurt of the present invention was found to have superior antioxidant activity compared to commercial products.
시험예 2: 쌀겨 요구르트의 폴리페놀 분석Test Example 2: Polyphenol analysis of rice bran yogurt
동결건조한 시료(시중 요구르트, 당 2% 미강스타터 40% 함유 요구르트, 당 2% 미강스타터 50% 함유 요구르트)를 각각 정량하여 DW로 희석하고, 각각 농도 별로 시료를 50㎕씩 ep tube에 정량 분주한 다음 1% Na2CO3용액 900㎕씩 정량 분주한 다음 보텍싱(voltexing) 하였다.Freeze-dried samples (commercial yogurt, yogurt containing 2% sugar, 40% rice bran starter, yogurt containing 50% rice bran starter, 2% sugar) were each weighed and diluted with DW, and 50㎕ of each concentration of sample was dispensed into ep tubes. Next, 900 ㎕ of 1% Na 2 CO 3 solution was dispensed quantitatively and then vortexed.
Folin & Ciocalteu’s phenol regent 50㎕를 혼합한 후 암소에서 30분 방치하고, TECAN을 이용하여 760nm로 흡광도 측정하고, 농도별로 희석한 Standard 그래프를 이용하여 시료 속에 포함되어 있는 폴리페놀양을 정량한 후 그 결과를 도 6에 나타내었다. 도 6은 쌀겨 배양액을 이용하여 제조한 요구르트의 폴리페놀 함량을 나타내느 그라프도이다.After mixing 50㎕ of Folin & Ciocalteu's phenol regent, leave in the dark for 30 minutes, measure absorbance at 760nm using TECAN, quantify the amount of polyphenol contained in the sample using a standard graph diluted by concentration, and then The results are shown in Figure 6. Figure 6 is a graph showing the polyphenol content of yogurt prepared using rice bran culture medium.
도 6의 결과로 부터 본 발명의 쌀겨 요구르트는 폴리페놀 함량에 있어서 시중 구입한 비교품에 비하여 더 높은 폴리페놀 함량을 나타내었다.From the results in Figure 6, the rice bran yogurt of the present invention showed a higher polyphenol content compared to commercially purchased comparative products.
시험예 3: 쌀겨 요구르트의 오르니틴 함량 분석Test Example 3: Analysis of ornithine content in rice bran yogurt
동결건조한 실시예 3의 쌀겨 요구르트에서 아미노산을 추출하여 Ornithine 함량 분석하였다. 시료를 EP tube에 200mg씩 넣고 free amino acid(methanol:chloroform:water=12:5:3) 시약 800μL을 넣고, 12,000RPM 15min 4℃에서 원심분리를 돌린 후 상층액을 분리하였다.Amino acids were extracted from the freeze-dried rice bran yogurt of Example 3 and ornithine content was analyzed. Put 200 mg of the sample into an EP tube, add 800 μL of free amino acid (methanol:chloroform:water=12:5:3) reagent, and centrifuge at 12,000 RPM for 15 min at 4°C to separate the supernatant.
상층액을 분리한 후 고형물에 클로로포름 200μL과 3DW 400μL를 넣어 여분의 아미노산 추출하고, 12,000RPM 15min 4℃에서 원심분리를 돌린 후 상층액들을 합하여 필터링 후 TLC로 전개하여 Ornithine 함량 확인하고, Ornithine standard를 미리 전개시킨 후 스팟의 크기를 측정하여 기준표를 작성하고, 작성된 기준표를 사용하여 시료 속 Ornithine양을 계산하였다. R²값이 0.9이상인 그래프를 사용하여 계산하고, 그 결과를 도 7 및 8에 나타내었다. 도 7은 TLC 판을 이용하여 유산균의 오르니틴 생성율 확인하는 사진이고, 도 8은 오르니틴 스탠다드를 나타내는 그라프도이다.After separating the supernatant, add 200 μL of chloroform and 400 μL of 3DW to the solid to extract excess amino acids, centrifuge at 12,000 RPM for 15 minutes at 4°C, combine the supernatants, filter, and run TLC to check ornithine content. , After developing the ornithine standard in advance, the size of the spot was measured to create a standard table, and the amount of ornithine in the sample was calculated using the created standard table. It was calculated using a graph with an R² value of 0.9 or higher, and the results are shown in Figures 7 and 8. Figure 7 is a photograph confirming the ornithine production rate of lactic acid bacteria using a TLC plate, and Figure 8 is a graph showing the ornithine standard.
그 결과, 당 2% 미강스타터 40% 함유 요구르트는 29mg/mL, 당 2% 미강스타터 50% 함유 요구르트는 38mg/mL(동결건조 시킨 200mg 요구르트 시료 기준)로 나타났다.As a result, yogurt containing 2% sugar and 40% rice bran starter was found to be 29 mg/mL, and yogurt containing 50% sugar 2% rice bran starter was 38 mg/mL (based on a 200 mg freeze-dried yogurt sample).
시험예 4: 숙취해소 시험Test Example 4: Hangover relief test
시험에 참가한 패널 요원으로써 남성 50명을 실험대상으로 하였다. 실험군(5명)에게는 실시예 및 비교예의 요구르트를 음주 1시간 후 마시게 하였다. 대조군(5명)에게는 제품을 제공하지 않았다. 실험의 정확도를 가하기 위하여 본 실험이 있기 10일전부터 음주를 경험하지 못하게 하였다. 또한, 취하는 정도를 동일하게 하기 위하여, 소주 반병(120ml)을 1시간에 걸쳐 마시도록 하였다. 숙취평가 항목은 두통, 매스꺼움, 갈증, 피곤함 및 구토감의 총 5가지의 숙취가 해소되는 정도를 5점 만점 기준으로 평가하였다. 그 결과를 표 2에 나타내었다.The test subjects were 50 men as panel members who participated in the test. The experimental group (5 people) was made to drink the yogurt of Examples and Comparative Examples 1 hour after drinking. The control group (5 people) was not provided with any product. To ensure the accuracy of the experiment, the subjects were prohibited from drinking alcohol for 10 days prior to the experiment. Additionally, in order to equalize the level of intoxication, participants were asked to drink half a bottle (120 ml) of soju over 1 hour. The hangover evaluation items evaluated the degree to which a total of 5 hangovers - headache, nausea, thirst, fatigue, and nausea - were resolved on a 5-point scale. The results are shown in Table 2.
그 결과, 본 발명에 따른 쌀겨 요구르트는 음주 후 나타나는 숙취증상을 해소하는 효과가 있는 것으로 관찰되었으며, 특히, 음주 후 평소에 비하여 숙취증상이 나타나지 않았고, 숙취로 인해 속이 좋지 않아 아침식사를 하지 못하였으나 본 발명에 따른 요구르트를 복용한 다음 날은 아침식사를 하여도 속이 편한 것으로 조사되었다.As a result, it was observed that the rice bran yogurt according to the present invention is effective in relieving hangover symptoms that appear after drinking. In particular, hangover symptoms did not appear compared to usual after drinking, and I was unable to eat breakfast due to my stomach feeling bad due to the hangover. It was found that the day after taking the yogurt according to the present invention, the stomach felt comfortable even after eating breakfast.
시험예 5: 알코올 분해효소(ADH) 및 아세트알데히드 분해효소(ALDH) 활성 측정Test Example 5: Measurement of alcohol degrading enzyme (ADH) and acetaldehyde degrading enzyme (ALDH) activities
상기 실시예 및 비교예의 제품에 대하여 알코올 분해효소(ADH)와 아세트알데히드 분해효소(ALDH) 활성을 평가하였다.The products of the above examples and comparative examples were evaluated for alcohol decomposition enzyme (ADH) and acetaldehyde decomposition enzyme (ALDH) activities.
알코올 분해효소(ADH)는 간에서 생성되어 알코올을 분해하여 아세트알데히드를 만들어 내는 효소이며 상기 아세트알데히드 분해효소(ALDH)는 독성을 지니는 물질인 아세트알데히드를 아세트산과 물로 분해하는 효소이다. 숙취를 해소하는 데 있어서 가장 중요한 것은 알코올을 분해하는 효소들을 활성화시키는 것이다. 또한, 알코올 분해효소를 생성하는 간이 정상적인 역할을 할 수 있도록 간의 기능을 빠르게 회복시켜주는 것이 중요하다.Alcohol decomposition enzyme (ADH) is an enzyme produced in the liver that decomposes alcohol to produce acetaldehyde. Acetaldehyde decomposition enzyme (ALDH) is an enzyme that decomposes acetaldehyde, a toxic substance, into acetic acid and water. The most important thing in relieving a hangover is activating the enzymes that break down alcohol. Additionally, it is important to quickly restore liver function so that the liver, which produces alcohol-degrading enzymes, can perform its normal role.
상기 알코올 탈분해효소(ADH) 및 아세트알데히드 분해효소(ALDH)의 활성 평가는 알코올 및 아세트알데히드 분석 키트를 사용하여 실시예 2 내지 3 및 비교예 의 시료들에 대하여 알코올 분해 활성을 측정하였다. 각 시료의 처리군과 대조군(증류수)을 DMSO(dimethyl sulfoxide)에 10 ㎍/㎕ 농도로 녹여 실험에 사용하였고, 모든 실험군에서 알코올 탈수소효소(Alcohol Dehydrogenase, ADH)와 아세트알데히드 탈수소효소(Acetaldehyde dehydrogenase, ALDH)의 활성을 자외선분광광도기(UVspectrophotometer)를 사용하여 340nm에서 흡광도를 측정하였다. 각 시료의 활성은 in vitro assay system을 이용하여 측정하여 대조구에 대한 상대율로 표시하였다. 실험결과는 다음의 표 3에 나타내었다.To evaluate the activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH), the alcohol decomposition activity was measured for the samples of Examples 2 and 3 and Comparative Example using an alcohol and acetaldehyde analysis kit. The treatment group and control group (distilled water) of each sample were dissolved in DMSO (dimethyl sulfoxide) at a concentration of 10 ㎍/㎕ and used in the experiment. Alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (Acetaldehyde dehydrogenase) in all experimental groups were used in the experiment. The activity of ALDH) was measured by absorbance at 340 nm using an ultraviolet spectrophotometer. The activity of each sample was measured using an in vitro assay system and expressed as a relative rate to the control. The experimental results are shown in Table 3 below.
그 결과, 대조군(Control, 증류수)에 비해 실시예의 시료들은 비교예의 것에 비하여 높은 ADH와 ALDH의 활성을 보였으며, 이는 알코올의 섭취 전후에 시료를 섭취하였을 때 간기능 보호 효과가 있음을 확인할 수 있다.As a result, compared to the control (distilled water), the samples of the example showed higher ADH and ALDH activities than those of the comparative example, which confirms that there is a liver function protection effect when the sample is ingested before and after the ingestion of alcohol. .
시험예 6: 관능 검사 시험Test Example 6: Sensory test
상기 실시예 2 내지 3 및 비교예의 요구르트에 대하여 관능검사를 실시하였다. 패널은 훈련된 검사원 30명을 선정하여 외관, 향, 맛, 종합적 기호도를 다음과 같은 5점척도법에 의해 평가하고 각각의 값을 평균하여 결과를 다음의 표 4에 나타내었다. 평가 기준은 매우 양호한 정도를 5로 하고, 약간 양호한 정도는 4, 보통의 정도는 3, 열악한 정도는 2, 아주 열악한 경우는 1로 정하였다.A sensory test was conducted on the yogurts of Examples 2 to 3 and Comparative Examples. The panel selected 30 trained inspectors and evaluated appearance, aroma, taste, and overall preference using the following 5-point scale method, averaged each value, and presented the results in Table 4 below. The evaluation criteria were 5 for very good, 4 for slightly good, 3 for average, 2 for poor, and 1 for very poor.
상기 표 4의 결과에서 확인할 수 있는 바와 같이, 본 발명의 실시예의 쌀 겨 요구르트 제품은 외관, 맛, 및 전체적인 기호도에 있어서, 비교예에 비해 전반적으로 우수한 효과가 있음을 확인하였다. As can be seen from the results in Table 4, it was confirmed that the rice bran yogurt product of the example of the present invention had an overall superior effect compared to the comparative example in terms of appearance, taste, and overall preference.
이상 설명한 바와 같이, 본 발명에 따른 쌀겨 요구르트는 오르니틴 함량이 증대될 뿐만 아니라 우유의 사용량이 줄어 제조비용을 줄일 수 있고, 그뿐만 아니라 미강고형물을 폐기하지 않고 제품으로 만들었기 때문에 미강에 잔류하는 영양분을 효율적으로 섭취할 수 있다.As described above, the rice bran yogurt according to the present invention not only has an increased ornithine content, but also reduces the amount of milk used, thereby reducing manufacturing costs. Moreover, because it is made into a product without discarding rice bran solids, the rice bran yogurt does not waste any residue in the rice bran. Nutrients can be consumed efficiently.
이상 본 발명은 바람직한 실시예를 참조하여 설명하였지만, 해당 기술 분야의 숙련된 당업자는 하기의 특허 청구의 범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다.Although the present invention has been described above with reference to preferred embodiments, those skilled in the art can make various modifications and changes to the present invention without departing from the spirit and scope of the invention as set forth in the claims below. You will understand that it is possible.
Claims (4)
b) 발효식품에서 분리한 유산균 균주를 MRS 배지에서 반복 배양하여 균을 활성화시키는 단계;
c) 오르니틴 형성이 확인된 유산균 균주를 1% 아르기닌(Arginine)을 첨가한 MRS 배지에 접종하는 단계;
d) 유산균 균주가 접종된 배지를 37℃에서 48시간 동안 1차 배양하는 단계;
e) 배양이 완료된 배지를 3,500 RPM에서 20분 동안 원심분리하여 유산균과 배지를 분리하는 단계;
f) 배지에서 분리한 유산균에 멸균수를 넣어 세척하는 단계;
g) 세척된 유산균에 쌀겨 배지를 첨가한 후 37℃에서 48시간 동안 2차배양하는 단계;
h) 유산균이 배양된 쌀겨 배지에 설탕 및 우유를 첨가하여 37℃에서 6시간 동안 발효시켜 쌀겨 요구르트를 제조하는 단계 ;
i) 제조된 쌀겨 요구르트를 일정 단위로 포장하는 단계; 및
j) 포장된 쌀겨 요구르트를 냉장 보관하는 단계;를 포함하는 것을 특징으로 하는 쌀겨 요구르트의 제조 방법.a) preparing a rice bran medium by adding rice bran or rice bran extract and arginine to distilled water and sterilizing it at 121°C for 20 minutes;
b) repeatedly culturing the lactic acid bacteria strain isolated from fermented food in MRS medium to activate the bacteria;
c) inoculating the lactic acid bacteria strain confirmed to form ornithine into MRS medium supplemented with 1% arginine;
d) primary culturing the medium inoculated with the lactic acid bacteria strain at 37°C for 48 hours;
e) centrifuging the cultured medium at 3,500 RPM for 20 minutes to separate the lactic acid bacteria and the medium;
f) washing the lactic acid bacteria isolated from the medium with sterilized water;
g) Adding rice bran medium to the washed lactic acid bacteria and then secondary culturing at 37°C for 48 hours;
h) adding sugar and milk to the rice bran medium cultured with lactic acid bacteria and fermenting it at 37°C for 6 hours to produce rice bran yogurt;
i) packaging the prepared rice bran yogurt in a certain unit; and
j) A method of producing rice bran yogurt comprising the step of refrigerating the packaged rice bran yogurt.
상기 유산균은
a1) 발효 식품을 펩톤수로 희석하는 단계;
a2) 희석액을 BCP 배지로 배양하는 단계;
a3) 배양이 완료된 배지로 부터 환을 형성하지 않으면서 진한 황색을 띄는 콜로니를 분리하는 단계; 및
a4) 분리된 균주의 오르니틴 생산능을 TLC에 의해 확인하는 단계;에 의해 활성화를 확인하는 것을 특징으로 하는 쌀겨 요구르트의 제조 방법.In claim 1,
The lactic acid bacteria are
a1) diluting the fermented food with peptone water;
a2) culturing the diluted solution with BCP medium;
a3) Isolating dark yellow colonies without forming rings from the culture medium; and
a4) Confirming the ornithine production ability of the isolated strain by TLC; A method for producing rice bran yogurt, characterized in that activation is confirmed by.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220078992A KR20240001982A (en) | 2022-06-28 | 2022-06-28 | Yogurt using rice bran ferment and process for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220078992A KR20240001982A (en) | 2022-06-28 | 2022-06-28 | Yogurt using rice bran ferment and process for preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240001982A true KR20240001982A (en) | 2024-01-04 |
Family
ID=89542645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220078992A KR20240001982A (en) | 2022-06-28 | 2022-06-28 | Yogurt using rice bran ferment and process for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20240001982A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990047128A (en) | 1997-12-02 | 1999-07-05 | 김강권 | Method of manufacturing functional yogurt using wolfberry |
KR20090048903A (en) | 2007-11-12 | 2009-05-15 | 한국식품연구원 | Method for manufacturing of multifunctional soy yogurt containing monascus-fermented soy extracts |
KR101328362B1 (en) | 2011-08-02 | 2013-11-11 | 순천대학교 산학협력단 | The yogurt added with turbid rice-wine and preparing method thereof |
KR101846277B1 (en) | 2016-10-12 | 2018-04-06 | 인제대학교 산학협력단 | Sweet potato yogurt and a method of manufacturing the same |
KR20200066985A (en) | 2018-12-03 | 2020-06-11 | 서해수산푸드 주식회사 | Method for Preparing Milktea-Yogurt Enhancing Antioxidation Function |
-
2022
- 2022-06-28 KR KR1020220078992A patent/KR20240001982A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990047128A (en) | 1997-12-02 | 1999-07-05 | 김강권 | Method of manufacturing functional yogurt using wolfberry |
KR20090048903A (en) | 2007-11-12 | 2009-05-15 | 한국식품연구원 | Method for manufacturing of multifunctional soy yogurt containing monascus-fermented soy extracts |
KR101328362B1 (en) | 2011-08-02 | 2013-11-11 | 순천대학교 산학협력단 | The yogurt added with turbid rice-wine and preparing method thereof |
KR101846277B1 (en) | 2016-10-12 | 2018-04-06 | 인제대학교 산학협력단 | Sweet potato yogurt and a method of manufacturing the same |
KR20200066985A (en) | 2018-12-03 | 2020-06-11 | 서해수산푸드 주식회사 | Method for Preparing Milktea-Yogurt Enhancing Antioxidation Function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109717340B (en) | Fermentation preparation method of two-step cordyceps militaris enzyme combined with composite enzymolysis | |
JP5917772B2 (en) | A method for producing fermented red ginseng concentrate with enhanced content of compound K using enzyme conversion and lactic acid bacteria fermentation, and a product containing fermented red ginseng concentrate produced by the production method as an active ingredient. | |
CN110100899B (en) | Method for preparing fermented soybean milk powder from lactobacillus fermentum, prepared fermented soybean milk powder and application | |
KR20150041519A (en) | latic acid bacteria fruit fermented liquor, latic acid bacteria fermentation fruit beverage and manufacturing method thereof | |
CN107372825A (en) | A kind of blueberry milk beer drink and its production method | |
CN103181414A (en) | Anti-ageing yoghourt containing flavonoid compounds and production method for same | |
CN103404593B (en) | Black tea sugarcane juice yoghourt and preparation method thereof | |
ÖZYURT | Changes in the content of total polyphenols and the antioxidant activity of different beverages obtained by Kombucha ‘tea fungus’ | |
CN110122576B (en) | Method for preparing fermented soybean milk by lactobacillus fermentum, prepared fermented soybean milk and application | |
CN107334025A (en) | A kind of blueberry fermented beverage | |
JP2005278517A (en) | Lactic fermented food containing mulberry fruit juice | |
JP6955808B1 (en) | How to make fermented honey | |
Lee et al. | Changes in chemical composition and sensory qualities of peanut milk fermented with lactic acid bacteria | |
CN103181413A (en) | Anti-ageing lactobacillus beverage containing flavonoid compounds and production method for same | |
JP2020061977A (en) | Novel lactic acid bacterium that belongs to streptococcus salivarius, and use of the same | |
CN114304620B (en) | Xinjiang medicine mulberry compound enzyme fermented by compound bacteria and preparation method thereof | |
KR20240001982A (en) | Yogurt using rice bran ferment and process for preparing the same | |
KR20160066464A (en) | Method of Manufacturing Aronia Yogurt, and Aronia Yogurt Manufactured by the same Method | |
KR20200004179A (en) | Aronia fermented beverage with antioxidant function and method for manufacturing the same | |
CN114365809B (en) | Ginseng fermented beverage rich in saponins and preparation method thereof | |
JPH0851955A (en) | Production of solution having high content of water-soluble vitamin | |
CN109527308A (en) | A kind of probiotics drink and preparation method thereof with coordinating intestines and stomach function | |
KR102055053B1 (en) | Starter containing of lactic acid bacteria with superior effect for alcohol degradation activity and cheese containing alcohol metabolism using the same | |
CN111500642B (en) | Blueberry fermentation product and preparation method and application thereof | |
CN107080130A (en) | A kind of preparation method of lucidum spore powder ferment health drink |